NAV
₹52.2060
as of 29 Sept 2026
Expense Ratio
0.61%
Lumpsum returns (CAGR)
- 1Y
- +23.69%
- 3Y
- +22.60%
- 5Y
- +15.89%
- Since Inception
- +22.20%
SIP returns (XIRR)
- 1Y
- +29.10%
- 3Y
- +19.79%
- 5Y
- +20.84%
- Since Inception
- +22.40%
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Pharmaceuticals & Biotechnology75.40%
- Healthcare Services21.74%
- Healthcare Equipment & Supplies1.44%
- Chemicals & Petrochemicals1.09%
Each sector links to the mutual funds most exposed to it.
Thinking about Mirae Asset Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Mirae Asset Healthcare Fund - Direct Plan - IDCW
- 1Sun Pharmaceutical Industries Ltd.10.90%
- 2Divi'S Laboratories Ltd.9.91%
- 3Torrent Pharmaceuticals Ltd.7.06%
- 4Apollo Hospitals Enterprise Ltd.5.91%
- 5Laurus Labs Ltd.5.24%
- 6Glenmark Pharmaceuticals Ltd.4.99%
- 7Dr. Reddy'S Laboratories Ltd.3.94%
- 8Aurobindo Pharma Ltd.3.81%
- 9Ipca Laboratories Ltd.3.43%
- 10Fortis Healthcare Ltd.3.40%
What this fund does
Mirae Asset Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Mirae Asset Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Mirae Asset Mutual Fund. The fund has been operational for over 8 years. The current expense ratio is 0.61%.